Aberdeen Group
IDYA icon

Aberdeen Group’s IDEAYA Biosciences IDYA Stock Holding History

Aberdeen Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.2M Sell
545,631
-14,992
-3% -$503K 0.03% 452
2025
Q4 		$19.4M Buy
560,623
+2,575
+0.5% +$82.1K 0.03% 441
2025
Q3 		$15.2M Buy
558,048
+116,743
+26% +$2.82M 0.02% 522
2025
Q2 		$9.28M Hold
441,305
– – 0.02% 614
2025
Q1 		$7.23M Buy
441,305
+134,582
+44% +$2.87M 0.01% 633
2024
Q4 		$7.88M Buy
306,723
+73,893
+32% +$2.09M 0.01% 556
2024
Q3 		$7.38M Buy
+232,830
New +$8.83M 0.01% 579
2021
Q1 		– Sell
-13,320
Closed -$201K – 994
2020
Q4 		$201K Buy
+13,320
New +$180K ﹤0.01% 944

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return